Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-34,116
Closed -$870K 615
2017
Q2
$870K Sell
34,116
-10,717
-24% -$256K 0.01% 668
2017
Q1
$1.08M Sell
44,833
-8,187
-15% -$172K 0.02% 636
2016
Q4
$899K Sell
53,020
-1,550
-3% -$28.6K 0.02% 638
2016
Q3
$1.31M Buy
54,570
+39,350
+259% +$1.03M 0.02% 564
2016
Q2
$405K Buy
15,220
+5,810
+62% +$170K 0.01% 773
2016
Q1
$259K Buy
+9,410
New +$227K ﹤0.01% 808

Other funds holding CLLS

GAM Holding's CLLS Position: Q3 2017 in Review

GAM Holding sold out of Cellectis (CLLS) in Q3 2017, closing a stake of 34,116 shares — an estimated $870K sold.

GAM Holding first reported a position in CLLS in Q1 2016 and held it in 6 quarters. The position peaked at $1.31M in Q3 2016. 42 funds tracked by Wall St. Rank hold CLLS as of Q3 2017.

  • GAM Holding reported no remaining Cellectis position as of Q3 2017 after selling out during the quarter.
  • GAM Holding sold 34,116 Cellectis shares in Q3 2017, an estimated $870K.
  • GAM Holding first reported a position in Cellectis in Q1 2016 and held it in 6 quarters.
  • GAM Holding's Cellectis position peaked at $1.31M in Q3 2016.
  • 42 funds tracked by Wall St. Rank held Cellectis as of Q3 2017.

Based on GAM Holding's 13F filing for Q3 2017, filed 14 Nov 2017.